Report Detail
Global Antipsychotic Medications Market Growth 2019-2024
- RnM3128225 |
- 14 March, 2019 |
- Global |
- 134 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Antipsychotics medication are a group of drugs that are used to treat serious mental health conditions such as psychosis as well as other emotional and mental conditions.
According to this study, over the next five years the Antipsychotic Medications market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Antipsychotic Medications business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Antipsychotic Medications market by product type, application, key manufacturers and key regions and countries.
This study considers the Antipsychotic Medications value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Selective Serotonin Reuptake Inhibitors (SSRIs)
Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Tricyclic Antidepressants (TCAs)
Monoamine Oxidase Inhibitors (MAOIs)
Reversible Inhibitors of Monoamine Oxidase-A (RIMA)
Tetracyclic Antidepressants (TeCAs)
Noradrenergic and Specific Serotonergic Antidepressant (NaSSAs)
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital Pharmacies
Drug Stores
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Johnson and Johnson
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Novartis
Allergan
Pfizer
GlaxoSmithKline
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Antipsychotic Medications consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Antipsychotic Medications market by identifying its various subsegments.
Focuses on the key global Antipsychotic Medications manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Antipsychotic Medications with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Antipsychotic Medications submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Antipsychotic Medications Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Antipsychotic Medications Consumption 2014-2024
- 2.1.2 Antipsychotic Medications Consumption CAGR by Region
- 2.2 Antipsychotic Medications Segment by Type
- 2.2.1 Selective Serotonin Reuptake Inhibitors (SSRIs)
- 2.2.2 Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
- 2.2.3 Tricyclic Antidepressants (TCAs)
- 2.2.4 Monoamine Oxidase Inhibitors (MAOIs)
- 2.2.5 Reversible Inhibitors of Monoamine Oxidase-A (RIMA)
- 2.2.6 Tetracyclic Antidepressants (TeCAs)
- 2.2.7 Noradrenergic and Specific Serotonergic Antidepressant (NaSSAs)
- 2.3 Antipsychotic Medications Consumption by Type
- 2.3.1 Global Antipsychotic Medications Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Antipsychotic Medications Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Antipsychotic Medications Sale Price by Type (2014-2019)
- 2.4 Antipsychotic Medications Segment by Application
- 2.4.1 Hospital Pharmacies
- 2.4.2 Drug Stores
- 2.4.3 Others
- 2.5 Antipsychotic Medications Consumption by Application
- 2.5.1 Global Antipsychotic Medications Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Antipsychotic Medications Value and Market Share by Application (2014-2019)
- 2.5.3 Global Antipsychotic Medications Sale Price by Application (2014-2019)
3 Global Antipsychotic Medications by Players
- 3.1 Global Antipsychotic Medications Sales Market Share by Players
- 3.1.1 Global Antipsychotic Medications Sales by Players (2017-2019)
- 3.1.2 Global Antipsychotic Medications Sales Market Share by Players (2017-2019)
- 3.2 Global Antipsychotic Medications Revenue Market Share by Players
- 3.2.1 Global Antipsychotic Medications Revenue by Players (2017-2019)
- 3.2.2 Global Antipsychotic Medications Revenue Market Share by Players (2017-2019)
- 3.3 Global Antipsychotic Medications Sale Price by Players
- 3.4 Global Antipsychotic Medications Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Antipsychotic Medications Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Antipsychotic Medications Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Antipsychotic Medications by Regions
- 4.1 Antipsychotic Medications by Regions
- 4.1.1 Global Antipsychotic Medications Consumption by Regions
- 4.1.2 Global Antipsychotic Medications Value by Regions
- 4.2 Americas Antipsychotic Medications Consumption Growth
- 4.3 APAC Antipsychotic Medications Consumption Growth
- 4.4 Europe Antipsychotic Medications Consumption Growth
- 4.5 Middle East & Africa Antipsychotic Medications Consumption Growth
5 Americas
- 5.1 Americas Antipsychotic Medications Consumption by Countries
- 5.1.1 Americas Antipsychotic Medications Consumption by Countries (2014-2019)
- 5.1.2 Americas Antipsychotic Medications Value by Countries (2014-2019)
- 5.2 Americas Antipsychotic Medications Consumption by Type
- 5.3 Americas Antipsychotic Medications Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Antipsychotic Medications Consumption by Countries
- 6.1.1 APAC Antipsychotic Medications Consumption by Countries (2014-2019)
- 6.1.2 APAC Antipsychotic Medications Value by Countries (2014-2019)
- 6.2 APAC Antipsychotic Medications Consumption by Type
- 6.3 APAC Antipsychotic Medications Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Antipsychotic Medications by Countries
- 7.1.1 Europe Antipsychotic Medications Consumption by Countries (2014-2019)
- 7.1.2 Europe Antipsychotic Medications Value by Countries (2014-2019)
- 7.2 Europe Antipsychotic Medications Consumption by Type
- 7.3 Europe Antipsychotic Medications Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Antipsychotic Medications by Countries
- 8.1.1 Middle East & Africa Antipsychotic Medications Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Antipsychotic Medications Value by Countries (2014-2019)
- 8.2 Middle East & Africa Antipsychotic Medications Consumption by Type
- 8.3 Middle East & Africa Antipsychotic Medications Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Antipsychotic Medications Distributors
- 10.3 Antipsychotic Medications Customer
11 Global Antipsychotic Medications Market Forecast
- 11.1 Global Antipsychotic Medications Consumption Forecast (2019-2024)
- 11.2 Global Antipsychotic Medications Forecast by Regions
- 11.2.1 Global Antipsychotic Medications Forecast by Regions (2019-2024)
- 11.2.2 Global Antipsychotic Medications Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Antipsychotic Medications Forecast by Type
- 11.8 Global Antipsychotic Medications Forecast by Application
12 Key Players Analysis
- 12.1 Johnson and Johnson
- 12.1.1 Company Details
- 12.1.2 Antipsychotic Medications Product Offered
- 12.1.3 Johnson and Johnson Antipsychotic Medications Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Johnson and Johnson News
- 12.2 Eli Lilly
- 12.2.1 Company Details
- 12.2.2 Antipsychotic Medications Product Offered
- 12.2.3 Eli Lilly Antipsychotic Medications Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Eli Lilly News
- 12.3 Bristol-Myers Squibb
- 12.3.1 Company Details
- 12.3.2 Antipsychotic Medications Product Offered
- 12.3.3 Bristol-Myers Squibb Antipsychotic Medications Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Bristol-Myers Squibb News
- 12.4 AstraZeneca
- 12.4.1 Company Details
- 12.4.2 Antipsychotic Medications Product Offered
- 12.4.3 AstraZeneca Antipsychotic Medications Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 AstraZeneca News
- 12.5 Novartis
- 12.5.1 Company Details
- 12.5.2 Antipsychotic Medications Product Offered
- 12.5.3 Novartis Antipsychotic Medications Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Novartis News
- 12.6 Allergan
- 12.6.1 Company Details
- 12.6.2 Antipsychotic Medications Product Offered
- 12.6.3 Allergan Antipsychotic Medications Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Allergan News
- 12.7 Pfizer
- 12.7.1 Company Details
- 12.7.2 Antipsychotic Medications Product Offered
- 12.7.3 Pfizer Antipsychotic Medications Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Pfizer News
- 12.8 GlaxoSmithKline
- 12.8.1 Company Details
- 12.8.2 Antipsychotic Medications Product Offered
- 12.8.3 GlaxoSmithKline Antipsychotic Medications Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 GlaxoSmithKline News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Antipsychotic Medications . Industry analysis & Market Report on Antipsychotic Medications is a syndicated market report, published as Global Antipsychotic Medications Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Antipsychotic Medications market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
